Unknown

Dataset Information

0

NBM-HD-1: A Novel Histone Deacetylase Inhibitor with Anticancer Activity.


ABSTRACT: HDAC inhibitors (HDACis) have been developed as promising anticancer agents in recent years. In this study, we synthesized and characterized a novel HDACi, termed NBM-HD-1. This agent was derived from the semisynthesis of propolin G, isolated from Taiwanese green propolis (TGP), and was shown to be a potent suppressor of tumor cell growth in human breast cancer cells (MCF-7 and MDA-MB-231) and rat glioma cells (C6), with an IC(50) ranging from 8.5 to 10.3??M. Western blot demonstrated that levels of p21((Waf1/Cip1)), gelsolin, Ac-histone 4, and Ac-tubulin markedly increased after treatment of cancer cells with NBM-HD-1. After NBM-HD-1 treatment for 1-4?h, p-PTEN and p-AKT levels were markedly decreased. Furthermore, we also found the anticancer activities of NBM-HD-1 in regulating cell cycle regulators. Treatment with NBM-HD-1, p21((Waf1/Cip1)) gene expression had markedly increased while cyclin B1 and D1 gene expressions had markedly decreased. On the other hand, we found that NBM-HD-1 increased the expressions of tumor-suppressor gene p53 in a dose-dependent manner. Finally, we showed that NBM-HD-1 exhibited potent antitumor activity in a xenograft model. In conclusion, this study demonstrated that this compound, NBM-HD-1, is a novel and potent HDACi with anticancer activity in vitro and in vivo.

SUBMITTER: Huang WJ 

PROVIDER: S-EPMC3199191 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

altmetric image

Publications

NBM-HD-1: A Novel Histone Deacetylase Inhibitor with Anticancer Activity.

Huang Wei-Jan WJ   Liang Yu-Chih YC   Chuang Shuang-En SE   Chi Li-Ling LL   Lee Chi-Yun CY   Lin Chia-Wei CW   Chen Ai-Ling AL   Huang Jing-Shi JS   Chiu Chun-Jung CJ   Lee Cheng-Feng CF   Huang Chung-Yang CY   Chen Chia-Nan CN  

Evidence-based complementary and alternative medicine : eCAM 20111020


HDAC inhibitors (HDACis) have been developed as promising anticancer agents in recent years. In this study, we synthesized and characterized a novel HDACi, termed NBM-HD-1. This agent was derived from the semisynthesis of propolin G, isolated from Taiwanese green propolis (TGP), and was shown to be a potent suppressor of tumor cell growth in human breast cancer cells (MCF-7 and MDA-MB-231) and rat glioma cells (C6), with an IC(50) ranging from 8.5 to 10.3 μM. Western blot demonstrated that level  ...[more]

Similar Datasets

| S-EPMC3393387 | biostudies-literature
| S-EPMC8640587 | biostudies-literature
| S-EPMC3425516 | biostudies-literature
| S-EPMC2292526 | biostudies-literature
| S-EPMC8704709 | biostudies-literature
| S-EPMC4808007 | biostudies-literature
| S-EPMC1896119 | biostudies-literature
| S-EPMC8822767 | biostudies-literature
| S-EPMC118000 | biostudies-literature
| S-EPMC7733455 | biostudies-literature